Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia

Affiliations

• ¹ Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group, University of Cologne, Germany.
• ² Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany.
• ³ Onkologie Ravensburg, Ravensburg, Germany.
• ⁴ Clinics Ostalb, Stauferklinikum, Mutlangen, Germany.
• ⁵ Ambulantes Krebszentrum, Frankfurt, Germany.
• ⁶ Klinik für Hämatologie, Onkologie und Gastroenterologie, Kliniken Maria Hilf GmbH, Mönchengladbach, Germany.
• ⁷ Luebecker Onkologische Schwerpunktpraxis, Luebeck, Germany.
• ⁸ Überörtliche Berufsausübungsgemeinschaft, Regensburg, Germany.
• ⁹ Department of Internal Medicine III, Ulm University, Germany.
• ¹⁰ Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilians-University, Munich, Germany.
• ¹¹ Department of Medicine II, University of Schleswig-Holstein, Kiel, Germany.
• ¹² Gilead Sciences, Inc., Foster City, CA, USA.